Urolithiasis pp 295-300 | Cite as

Uric Acid Nephrolithiasis

  • O. Sperling

Abstract

Uric acid nephrolithiasis refers to a group of conditions with specific etiologies leading to the formation of stones composed of uric acid or urate salts. In the case of mixed stones, the connotation ‘uric acid nephrolithiasis’ is justified only when the etiological evidence is compatible with the above definition. Several investigators have adopted a wider definition, regarding as uric-acid stone patients all patients whose stones were found to contain uric acid or urate (1).

Keywords

Uric Acid Glycogen Storage Disease Uric Acid Stone High Ammonium Concentration Uric Acid Crystal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    CY Pak, F Britton, R Peterson, D Ward, C Northcutt, NA Breslau, J McGuire, K Sakhee, S Bush, M Nicar, DA Norman, and P Peters, Am. J. Med. 69: 19 (1980).PubMedCrossRefGoogle Scholar
  2. 2.
    JL Miller, Medical History 1: 400 (1929).Google Scholar
  3. 3.
    A Butt, “Etiological Factors in Urolithiasis”, Charles C Thomas, Springfield, Illinois (1956).Google Scholar
  4. 4.
    GD Williams, J. Am. Med. Assoc. 87: 941 (1926).CrossRefGoogle Scholar
  5. 5.
    A Atsmon, A De Vries, M Frank, “Uric Acid Lithiasis”, Elsevier, Amsterdam (1963).Google Scholar
  6. 6.
    TF Yu, Uric Acid Handbook of Experimental Pharmacology 51: 397 (1978).CrossRefGoogle Scholar
  7. 7.
    A Hesse, HJ Schneider, W Berg, E Heinzsch, Invest. Urol. 12: 405 (1975).PubMedGoogle Scholar
  8. 8.
    AS Meyer, B Finlayson, and L Dubois, Br. J. Urol. 43: 154 (1964).CrossRefGoogle Scholar
  9. 9.
    O Sperling and A De Vries, J. Urol. 92: 331 (1964).PubMedGoogle Scholar
  10. 10.
    O Sperling, O Kedem, and A De Vries, Rev. Francaise d’Etud. Clin. Biol. 11: 40 (1966).Google Scholar
  11. 11.
    FL Coe, AL Strauss, V Tembe, and S Le Dun, Kidney Int. 17: 622 (1980).CrossRefGoogle Scholar
  12. 12.
    M Teotia and J Stuor, Br. J. Urol. 43: 381 (1971).PubMedCrossRefGoogle Scholar
  13. 13.
    M Teotia and SPS Teotia, Postgrad. Med. J. 53(Suppl. 2): 41 (1977).PubMedGoogle Scholar
  14. 14.
    O Sperling, A De Vries, and O Kedem, J. Urol. 94: 286 (1965).PubMedGoogle Scholar
  15. 15.
    N Zollner and A Griebsch, Adv. Exptl. Med. Biol. 41B: 433 (1974).Google Scholar
  16. 16.
    N Zollner, in: “Urolithiasis Research”, H Fleisch, WG Robertson, and LH Smith, eds., Plenum Press, New York (1976).Google Scholar
  17. 17.
    FL Coe, E Moran, and E Kavalich, J. Chronic Dis. 29: 793 (1976).PubMedCrossRefGoogle Scholar
  18. 18.
    A Halabe, R Samuel, UA Liberman, and O Sperling, Forts. Urol. Nephrol. 16: 70 (1981).Google Scholar
  19. 19.
    BT Emmerson, in: “Uric Acid, Handbook of Experimental Pharmacology”, 51: 287 (1978).CrossRefGoogle Scholar
  20. 20.
    DA McLain, FJ Garriga, and OS Kantor, J. Am. Med. Assoc. 243: 763 (1980).CrossRefGoogle Scholar
  21. 21.
    F Matzkies, Fortschr. Med. 96: 1619 (1978).PubMedGoogle Scholar
  22. 22.
    MW Johnson and WE Mitch, Drugs 21: 220 (1981).PubMedCrossRefGoogle Scholar
  23. 23.
    BT Emmerson, Adv. Exp. Med. Biol. 41B: 429 (1974).CrossRefGoogle Scholar
  24. 24.
    F Delbarre, C Auscher, H Brouihet and A de Gerry, Semaine des Hospitaus de Paris 43 (1967).Google Scholar
  25. 25.
    J Grunst, G Dietze, and M Wicklmayr, Nutr. and Metab. 21: 138 (1977).CrossRefGoogle Scholar
  26. 26.
    UA Liberman, R Samuel, A Halabe, H Joshua, E Lubin, and O Sperling, Arth. Rheu. 25: 1264 (1982).CrossRefGoogle Scholar
  27. 27.
    RW Watts, Postgrad. Med. J. 53(Suppl. 2): 7 (1977).PubMedGoogle Scholar
  28. 28.
    A De Vries and O Sperling, in: “Idiopathic Urinary Bladder Stone Disease”, R van Reem, ed., Fogarty International Center Proc. 37, Washington (1977).Google Scholar
  29. 29.
    A De Vries and O Sperling, in: “Scientific Foundation of Urology”, GD Chisholm and DI Williams, eds., William Heinemann Medical Books, London (1982).Google Scholar
  30. 30.
    M Lesch and WLA Nyhan, Am. J. Med. 36: 561 (1964).PubMedCrossRefGoogle Scholar
  31. 31.
    WM Kelley, ML Green, FM Rosenbloom, JF Henderson, and JE Seegmiller, Ann. Int. Med. 70: 155 (1969).PubMedCrossRefGoogle Scholar
  32. 32.
    O Sperling, S Persky-Brosh, P Boer, and A De Vries, in: “Urinary Calculi. Recent Advances in Etiology, Stone Structure, and Treatment”, L Cifuentes De Latte, R Rapado, and H Hogkinson, eds., Karger, Basel (1972).Google Scholar
  33. 33.
    O Sperling, G Eilam, S Persky-Brosh, and A De Vries, Biochem. Med. 6: 310 (1972).PubMedCrossRefGoogle Scholar
  34. 34.
    O Sperling, S Persky-Brosh, P Boer, and A De Vries, Biochem. Med. 7: 389 (1973).PubMedCrossRefGoogle Scholar
  35. 35.
    E Zoref, A De Vries, and O Sperling, J. Clin. Invest. 56: 1093 (1975).PubMedCrossRefGoogle Scholar
  36. 36.
    MA Becker, LJ Meyer, PJ Kostel, and JE Seegmiller, Adv. Exptl. Med. Biol. 41A: 307 (1974).CrossRefGoogle Scholar
  37. 37.
    RR Howell, Arth. and Rheu. 8: 780 (1965).CrossRefGoogle Scholar
  38. 38.
    A De Vries and O Sperling, Biomedicine 30: 75 (1979).PubMedGoogle Scholar
  39. 39.
    O Sperling, in: “The Metabolic Basis of Inherited Disease”, 6th Edition, CR Scriver, AC Baudet, WS Sly, and D Valee, eds., McGraw-Hill, New York. In press, 1988.Google Scholar
  40. 40.
    JB Wyngaarden and WN Kelley, “Gout and Hyperuricemia”, Grune and Stratton, New York (1976).Google Scholar
  41. 41.
    AB Gutman and TF Yu, Am. J. Med. 45: 657 (1968).CrossRefGoogle Scholar
  42. 42.
    AB Gutman and TF Yu, Am. J. Med. 35: 820 (1963).PubMedCrossRefGoogle Scholar
  43. 43.
    CYC Pak, C Skurla, and J Harvey, J. Urol. 134: 867 (1985).PubMedGoogle Scholar
  44. 44.
    S Millman, AL Strauss, JH Parks, and FL Coe, Kidney Int. 22: 366 (1982).PubMedCrossRefGoogle Scholar
  45. 45.
    O Sperling, in: “Renal Tract Stone. Metabolic Basis and Clinical Practice”, JEA Wickham and AC Buck, eds., Churchill Livingstone, London. In press, 1988.Google Scholar
  46. 46.
    O Sperling, A Atsmon, and A De Vries, New Istanbul Contribution to Clin. Sci. 7: 227 (1964).Google Scholar
  47. 47.
    RW Rundles, JB Wyngaarden, G Hitchings, GB Elion, and HR Silberman, Trans. Assoc. Am. Physicians 76: 126 (1963).Google Scholar
  48. 48.
    ML Greene, WY Fujimoto, and JE Seegmiller, NEJM 280: 426 (1969). 49.PubMedCrossRefGoogle Scholar
  49. 49.
    O Sperling, S Brosh, P Boer, U Liberman, and A De Vries, Israel J. Med. Sci. 14: 288 (1978).PubMedGoogle Scholar
  50. 50.
    I Shoet, M Aladjem, D Lotan, D Katznelson, O Sperling, and G Kende, Int. J. Pediatric Nephrol. 1: 204 (1980).Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • O. Sperling
    • 1
    • 2
  1. 1.Clinical BiochemistryBeilinson Medical CenterPetah-TikvaIsrael
  2. 2.Departments of Chemical Pathology, Sackler School of MedicineTel-Aviv UniversityIsrael

Personalised recommendations